Evidence in Digital Therapeutics – Proof and Power

The key differentiator between ‘digital health and wellbeing technologies’ and ‘digital therapeutics’ is that the latter must show improved outcomes. Approximately 140 studies were published in 2017 which contained clinical evidence of digital health efficacy [1]. Clinically validated technologies have looked to show value for health systems by reducing emergency hospitalisation, A&E, ambulatory, drug and…

The rise of digital health and its implications for healthcare and real world evidence

Despite being one of the largest and most rapidly growing sectors in the world, the healthcare industry has generally stuck stringently to a reactive, treatment-focused model. However, with many services close to breaking point, and power shifting rapidly towards technology and the patient themselves, there is heightening pressure on the industry to capitalise on other…

How is Real World Data currently used by industry professionals?

We are excited to present our poster at the 23rd Annual International Society for Pharmacoeconomics and Outcomes Research Meeting #ISPORBaltimore today. The results being presented are from an exploratory survey suggesting that industry professionals recognise Real World Evidence (RWE) as important in supporting brand value messages and report a direct positive impact of RWE on…

pH Associates welcomes Myriam and Michael to our Scientific Consultant Team

Our Scientific Consultants are responsible for the writing of technically accurate, scientific deliverables to meet client and regulatory requirements. Such deliverables include, but are not limited to, study reports, publication manuscripts, abstracts and posters. Myriam Alexander is joining us as a scientific consultant, prior to joining pH Associates, Myriam worked as an Data Scientist – Analyst at…